| Adverse effects of treatment (Max. 2 points) | Digestive effects: gastritis, ulcer, intestinal alteration, liver disease... Neurological effects (drowsiness, altered consciousness ...) Immunosuppressive effects Cardiovascular effects: hypertension, hypotension, rhythm disturbance, thrombosis. Respiratory effects: irritation of the upper tract, bronchitis, pulmonary edema, pleurisy ... Kidney effects: kidney failure, lithiasis, nephritis ... Others: vertigo, tinnitus, visual disturbances | Mild ≤ 1 effects | 0.5 | |
| Moderate = 2 o 3 effects | 1 | |||
| Severe > 3 effects | 2 | |||
| Associated pathologies (max 2 points) * Only those pathologies that modify the course or prognosis of the neuropathic pain under evaluation are evaluated. |
| |||
| Traumatological | Yes | No | Mild = 1 associated pathology | 0 |
| Cardiological | Yes | No | ||
| Dermatological: important skin lesions (large scars for example) | Yes | No | Moderate = 2 associated pathologies | 1 |
| Vascular: arteriovenous or lymphatic lesions | Yes | No | ||
| Digestive: pathologies that interfere with the treatment | Yes | No | Severe = 3 or 4 associated pathologies | 1.5 |
| Psychiatric: conditions that coexist or interfere with the treatment | Yes | No | ||
| Autonomic nervous system disorders | Yes | No | Very severe: 5 or more associated pathologies | 2 |